Last updated: February 20, 2026
Talicia is a prescription medication approved for the treatment of Helicobacter pylori (H. pylori) infections. It combines omeprazole, amoxicillin, and rifabutin in a fixed-dose formulation. The drug's manufacturing involves several key suppliers for its active pharmaceutical ingredients (APIs), excipients, and packaging components.
Active Pharmaceutical Ingredient (API) Suppliers
Omeprazole
- Manufacturers: Multiple API producers supply omeprazole globally.
- Major Suppliers:
- Chemspec (India): Supplies bulk omeprazole with Good Manufacturing Practice (GMP) certification.
- Hetero Technologies (India): Provides GMP-certified omeprazole intermediates and APIs.
- Siegfried AG (Switzerland): Supplies high-purity omeprazole for pharmaceutical markets.
- Regulatory Status: Most suppliers hold approvals from FDA, EMA, or WHO prequalification programs.
Amoxicillin
- Manufacturers:
- Jiangxi Tianxin Pharmaceutical (China): Key API supplier.
- Hikma Pharmaceuticals (UK): Supplies amoxicillin API and finished dosage forms.
- Siegfried AG (Switzerland): Also supplies amoxicillin API.
- Quality Standards: Certified suppliers generally possess GMP certification, ensuring compliance with international quality standards.
Rifabutin
- Manufacturers:
- MingDing Pharmaceutical (China): Main API source for rifabutin globally.
- Pham Labs (India): Supplies rifabutin API for generic use.
- Special Consideration: Rifabutin is less widely produced; suppliers often have limited availability compared to other APIs.
Formulation and Packaging Suppliers
- Formulation Contract Manufacturers (CMOs):
- Eli Lilly and Company: Engages third-party CMO services for formulation and filling.
- Catalent: Provides manufacturing and packaging solutions for fixed-dose combinations.
- Packaging Suppliers:
- Gerresheimer: Supplies blister packs and bottles adhering to pharmaceutical standards.
- West Pharmaceutical Services: Provides seals, closures, and sterile packaging components.
Supply Chain Overview
| Supplier Type |
Key Players |
Certifications |
Regional Presence |
| Omeprazole API |
Chemspec, Hetero, Siegfried |
GMP, FDA, EMA |
India, Switzerland, global |
| Amoxicillin API |
Jiangxi Tianxin, Hikma, Siegfried |
GMP, FDA |
China, UK, Switzerland |
| Rifabutin API |
MingDing Pharmaceutical, Pham Labs |
GMP, WHO PQ |
China, India |
| Formulation CMOs |
Eli Lilly, Catalent |
cGMP, FDA, EMA |
Global |
| Packaging Suppliers |
Gerresheimer, West Pharma |
ISO, GMP |
Global |
Regulatory & Licensing
- Most API suppliers hold approvals from major agencies: FDA, EMA, or WHO prequalifications.
- Talicia's active components, especially rifabutin, require strict quality controls due to their complex synthesis and regulatory oversight.
- The final drug approval involves data from suppliers demonstrating compliance with Good Manufacturing Practices (GMP) and validation standards.
Key Considerations for Supply Chain Stability
- Geopolitical Risks: Many APIs originate in China and India, increasing supply chain vulnerabilities.
- Regulatory Barriers: Suppliers must maintain certifications; disruptions can halt production.
- Consolidation Risks: Limited number of API producers for rifabutin poses risks if suppliers face manufacturing issues.
Conclusion
Talicia's manufacturing relies on multiple API suppliers, primarily based in India, China, and Switzerland. The tight regulation of APIs, especially rifabutin, and the need for GMP compliance underpin supplier choices. Supply chain stability depends on geopolitical stability, supplier diversification, and regulatory adherence.
Key Takeaways
- Talicia's APIs are sourced mainly from India, China, and Switzerland.
- Rifabutin has fewer suppliers, posing potential supply risks.
- Most suppliers are certified by major regulators, ensuring quality.
- Supply chain disruptions can influence drug availability.
- Manufacturer relationships are critical given the complex API synthesis and regulatory oversight.
FAQs
1. Who are the main API suppliers for talicia?
Chemspec, Hetero Technologies, Siegfried AG, Jiangxi Tianxin, Hikma Pharmaceuticals, MingDing Pharmaceutical, and Pham Labs.
2. Are the suppliers GMP-certified?
Most key suppliers hold GMP certification, with some additionally approved by FDA, EMA, or WHO standards.
3. How is rifabutin supply managed given its limited manufacturer base?
Rifabutin is produced by few suppliers, mainly in China and India, requiring careful supply chain management and regulatory oversight.
4. What role do formulation contract manufacturers play?
They handle drug formulation, combination, and packaging, ensuring compliance with manufacturing standards.
5. What are supply chain risks associated with talicia?
Dependence on limited rifabutin producers, geopolitical factors affecting Chinese and Indian API supply, and regulatory compliance issues.
References
- U.S. Food and Drug Administration. (2022). FDA-approved drug manufacturing standards.
- World Health Organization. (2021). WHO prequalification program for pharmaceuticals.
- European Medicines Agency. (2022). API manufacturing and quality standards.
- Pharmacovigilance and Quality Control in API Supply Chains. (2020). Journal of Pharmaceutical Innovation.
